GAMMA Investing’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Sell
3,982
-248
-6% -$105K 0.06% 268
2026
Q1
$2M Buy
4,230
+134
+3% +$67.5K 0.09% 190
2025
Q4
$1.91M Buy
4,096
+509
+14% +$236K 0.1% 172
2025
Q3
$1.53M Buy
3,587
+345
+11% +$134K 0.08% 198
2025
Q2
$1.24M Sell
3,242
-1,689
-34% -$609K 0.08% 229
2025
Q1
$1.7M Buy
4,931
+737
+18% +$237K 0.13% 144
2024
Q4
$1.26M Sell
4,194
-2,292
-35% -$801K 0.11% 162
2024
Q3
$2.64M Buy
6,486
+5,196
+403% +$1.9M 0.26% 65
2024
Q2
$414K Buy
1,290
+204
+19% +$66.3K 0.06% 301
2024
Q1
$362K Buy
1,086
+72
+7% +$22K 0.07% 262
2023
Q4
$309K Buy
+1,014
New +$251K 0.08% 220

Other funds holding HCA

GAMMA Investing's HCA Position: Q2 2026 in Review

GAMMA Investing reduced its HCA Healthcare (HCA) stake by 5.9% in Q2 2026, selling an estimated $105K and leaving 3,982 shares worth $1.55M. The position accounts for 0.06% of the portfolio, ranked #268.

GAMMA Investing first reported a position in HCA in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.64M in Q3 2024. 342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • GAMMA Investing held 3,982 shares of HCA Healthcare worth $1.55M as of Q2 2026.
  • GAMMA Investing sold 248 HCA Healthcare shares in Q2 2026, an estimated $105K.
  • HCA Healthcare made up 0.06% of GAMMA Investing's portfolio in Q2 2026, its #268 holding.
  • GAMMA Investing first reported a position in HCA Healthcare in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's HCA Healthcare position peaked at $2.64M in Q3 2024.
  • 342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.